Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6871 to 6885 of 7707 results

  1. Preterm labour and birth - predicting preterm birth

    Discontinued [GID-NG10384]

    NICE guideline
    Discontinued

  2. Nivolumab for maintenance treatment of extensive stage small-cell lung cancer after chemotherapy [ID1264]

    Discontinued [GID-TA10365]

    Technology appraisal guidance
    Discontinued

  3. Preterm labour and birth - timing of cord clamping

    Discontinued [GID-NG10396]

    NICE guideline
    Discontinued

  4. Sintilimab with pemetrexed and platinum-based chemotherapy for untreated advanced non-squamous non-small-cell lung cancer [ID4050]

    Discontinued [GID-TA10934]

    Technology appraisal guidance
    Discontinued

  5. Intrapartum care for healthy women and babies - angle of episiotomy

    Discontinued [GID-NG10394]

    NICE guideline
    Discontinued

  6. Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

    Discontinued [GID-HST10019]

    Highly specialised technologies guidance
    Discontinued

  7. Nivolumab with ipilimumab for untreated PD-L1 positive unresectable or metastatic urothelial cancer [ID3829]

    Discontinued [GID-TA10707]

    Technology appraisal guidance
    Discontinued

  8. Ticagrelor for preventing stroke after previous ischaemic stroke or high-risk transient ischaemic attack [ID2689]

    Discontinued [GID-TA10663]

    Technology appraisal guidance
    Discontinued

  9. Terevalefim for treating delayed graft function after kidney transplant [ID1490]

    Discontinued [GID-TA11098]

    Technology appraisal guidance
    Discontinued

  10. Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID968]

    Discontinued [GID-TA10334]

    Technology appraisal guidance
    Discontinued

  11. Durvalumab with chemotherapy for untreated advanced non-small-cell lung cancer with no EGFR or ALK mutations [ID3751]

    Discontinued [GID-TA10616]

    Technology appraisal guidance
    Discontinued

  12. Surgical vessel sealing systems (MT798)

    In development [GID-MT594] Expected publication date: TBC

    Medical technologies guidance
    In development

  13. VTS-270 for treating Niemann-Pick type C1 [ID1267]

    In development [GID-HST10020] Expected publication date: TBC

    Highly specialised technologies guidance
    In development

  14. Nivolumab in combination for treating hormone-relapsed metastatic prostate cancer before chemotherapy [ID1619]

    Discontinued [GID-TA10490]

    Technology appraisal guidance
    Discontinued

  15. Haemochromatosis

    Discontinued [GID-NG10287]

    NICE guideline
    Discontinued